BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.39% | 47.66% | 43.90% | 49.43% | 36.09% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -89.05% | -182.07% | -66.10% | 134.24% | -36.17% |
| Total Other Non-Cash Items | -31.91% | 743.18% | 123.02% | -57.66% | -60.26% |
| Change in Net Operating Assets | -4,959.26% | -293.53% | -1,977.08% | 230.42% | 67.86% |
| Cash from Operations | 31.92% | 50.54% | 46.43% | 55.22% | 30.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -100.00% | 201.57% |
| Cash from Investing | -- | -100.00% | -100.00% | -100.00% | 201.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 41.50% | -11.33% | -117.00% | -300.00% | -- |
| Issuance of Common Stock | -33.19% | -36.10% | 81.94% | -38.08% | -49.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -28.52% | -52.59% | 70.53% | -57.75% | -67.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -243.72% | -677.44% | 116.37% | -7,253.70% | 435.02% |